GWM
EOLS icon

Geneos Wealth Management’s Evolus EOLS Stock Holding History

Geneos Wealth Management’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-512
Closed -$4.72K – 2702
2025
Q2 		$4.72K Buy
512
+494
+2,744% +$5.05K ﹤0.01% 2598
2025
Q1 		$2.07K Buy
+18
New +$235 ﹤0.01% 2756
2024
Q4 		– Sell
-36
Closed -$583 – 2905
2024
Q3 		$583 Buy
+36
New +$503 ﹤0.01% 2532
2019
Q1 		– Sell
-150
Closed -$1K – 2428
2018
Q4 		$1K Sell
150
-350
-70% -$4.99K ﹤0.01% 2295
2018
Q3 		$9K Sell
500
-465
-48% -$10.1K ﹤0.01% 1868
2018
Q2 		$27K Buy
+965
New +$17K ﹤0.01% 1326

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geneos Wealth Management's EOLS Position: Q3 2025 in Review

Geneos Wealth Management sold out of Evolus (EOLS) in Q3 2025, closing a stake of 512 shares — an estimated $4.72K sold.

Geneos Wealth Management first reported a position in EOLS in Q2 2018 and held it in 6 quarters. The position peaked at $27K in Q2 2018. 160 funds tracked by Wall St. Rank hold EOLS as of Q3 2025.

  • Geneos Wealth Management reported no remaining Evolus position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 512 Evolus shares in Q3 2025, an estimated $4.72K.
  • Geneos Wealth Management first reported a position in Evolus in Q2 2018 and held it in 6 quarters.
  • Geneos Wealth Management's Evolus position peaked at $27K in Q2 2018.
  • 160 funds tracked by Wall St. Rank held Evolus as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.